RTOG 97-06: Initial report of a Phase I–II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy
- 1 November 2003
- journal article
- clinical trial
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 57 (3), 665-672
- https://doi.org/10.1016/s0360-3016(03)00718-1
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancerUrology, 2002
- The Initial Results in Muscle-Invading Bladder Cancer of RTOG 95-06: Phase I/II Trial of Transurethral Surgery Plus Radiation Therapy with Concurrent Cisplatin and 5-Fluorouracil Followed by Selective Bladder Preservation or Cystectomy Depending on the Initial ResponseThe Oncologist, 2000
- Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03.Journal of Clinical Oncology, 1998
- Efficacy of Radiochemotherapy with Platin Derivatives Compared to Radiotherapy Alone in Organ-Sparing Treatment of Bladder CancerInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Invasive bladder cancer: Treatment strategies using transurethral surgery, chemotherapy and radiation therapy with selection for bladder conservationInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Bladder preservation by combined modality therapy for invasive bladder cancer.Journal of Clinical Oncology, 1997
- Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment timeRadiotherapy and Oncology, 1995
- Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study.Journal of Clinical Oncology, 1993
- Combined modality program with possible organ preservation for invasive bladder carcinoma: Results of rtog protocol 85-12International Journal of Radiation Oncology*Biology*Physics, 1993
- Dose fractionation and tumour repopulation in radiotherapy for bladder cancerRadiotherapy and Oncology, 1991